Home » cardiac
Tag:

cardiac

Health

Treviglio: Free Heart Screening & Cardiovascular Events

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Free Heart Health Screenings Available in⁢ Treviglio⁤ This⁤ week

treviglio, Italy – ASST ‍Bergamo Ovest ‌is hosting a “Cardiovascular ⁢Open Week” in treviglio from September 26th to ⁣October 2nd, offering free screenings and information aimed ⁤at promoting early diagnosis and prevention of cardiovascular diseases, including abdominal aortic aneurysm, atherosclerosis,⁣ stroke, ⁤and heart⁢ attack. ⁢The initiative, promoted by the Onda Foundation, ‍will feature an information gazebo in Piazza Cameroni and free exams at the Treviglio Hospital.

Residents ​of ASST Bergamo Ovest are​ encouraged to take advantage of the free‌ screenings available. On September 30th and october 2nd, appointments can‌ be made (via​ email​ to [email protected] until seats are filled) for either an ‌Ecocolordoppler of superioral trunks or an ⁤abdominal ⁣aorta ultrasound. These screenings are ⁣ reserved for resident women ‌who haven’t undergone these tests in‌ the last 12 months ⁤and have a medical indication ⁢for⁣ them.

Further opportunities for⁢ free testing include:

*⁤ September 27th: Free electrocardiograms will be ⁣offered in ⁣the Cardiology area of⁣ the Treviglio Hospital Poliambulatorio from 9:00 AM to 12:00 PM.Bookings can ⁣be⁤ made from September⁤ 23rd via WhatsApp message to 375.6481622.
* September 28th: Free cholesterol and blood ⁢sugar tests, along with blood pressure measurements, will be‌ available⁤ at a gazebo in ⁣Piazza Cameroni,⁢ organized in collaboration⁢ with the​ “Heart and Life” association, from 9:00 AM to 12:30 PM.

Giovanni ​Palazzo, DG of ASST Bergamo Ovest, emphasized the​ accessibility of preventative ‌care, ‍stating: “Making prevention, especially for cardiovascular diseases, ‌is crucial but also simple. Thanks to the control of lifestyles, especially in ​those who ⁢present risk or familiarity factors, important cardiovascular damage can be avoided.”⁣

Antonella Villa, director of ⁢midwife and gynecology,‌ added, “Cardiovascular diseases ⁢have more risk factors that have been identified over time and have potential reversibility: today these diseases are frequently ⁣enough considered foreseeable.”

The event ‌also‍ benefits from⁢ the support of the​ “Heart and Life” association, alongside cardiologists, vascular surgeons,​ and family‌ nurses and communities. Residents are ⁤urged to book appointments quickly as spaces are limited.

0 comments
0 FacebookTwitterPinterestEmail
Health

Vericiguat Drug: New Study Shows Improved Heart Failure Management

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Vericiguat: A New Hope for Heart Failure Patients – 100% Overview

This article‌ details ⁣the results of the VICTOR and VICTORIA studies⁣ regarding the drug vericiguat for treating heart failure. While the primary goal of reducing combined cardiovascular⁢ death or hospitalization wasn’t fully met, vericiguat demonstrated a​ important reduction in cardiovascular deaths and overall ‌mortality compared to placebo.

Key Findings & How Vericiguat Works:

Joint⁢ Analysis (Poled Analysis): combining data from the VICTOR and VICTORIA ⁤studies (over 11,000 patients) showed vericiguat can reduce serious events – hospitalizations and​ cardiovascular deaths – across the ⁣ entire spectrum of heart failure ‌severity.
 Mechanism​ of Action: vericiguat stimulates Soluble Guanylate Cyclase (SGC),‌ an enzyme deficient in the​ hearts of heart failure patients due to low nitric oxide levels. This stimulation improves blood vessel functionality ⁣ and helps the heart work more efficiently.
Broad-Spectrum Therapy: Unlike existing ‌treatments (ARNI, antialdosteronics, beta-blockers, and glifozines) which ⁣target specific phases of the disease, vericiguat possibly offers therapy throughout‌ the entire clinical course of heart failure.

Expert Outlook (Michele ⁢Senni):

Dr.⁢ Senni uses a ‌film analogy to explain the ⁢impact. Current drugs address isolated “frames” (acute crises‍ or stable phases). Vericiguat,⁣ however, aims to act throughout the​ entire “plot,” protecting patients in multiple phases and breaking⁣ the cycle of hospitalization and decline.

Impact & ​Prevalence ‍in Italy:

Heart⁢ failure affects ‍ over one million people in Italy,with 90,000 new cases annually.
It’s the ⁢ leading ⁤cause ⁢of hospitalization after ⁤age 65 and has ‌a high mortality​ rate – over 50% of patients die within five years of​ diagnosis.
 If⁢ confirmed⁤ by guidelines, vericiguat could significantly improve both quality of life and ⁢survival ​for these patients.

ASST ⁢Pope John XXIII’s Role:

‍The ⁢hospital’s Cardiovascular‌ Department,⁢ led by Dr. Michele Senni,​ played a⁣ leading and ‍coordinating role in the international trials.
 The hospital emphasizes the importance of research in⁣ translating advancements into patient care and highlights its commitment to cardiovascular​ risk prevention through projects like Bimberg.

In essence, vericiguat ‌represents a potentially significant ‌advancement in heart failure treatment, offering a novel approach that addresses‍ the disease‌ across its entire progression, rather than focusing on isolated events. Further ‍confirmation and guideline integration are needed to fully realize its impact.

0 comments
0 FacebookTwitterPinterestEmail
Technology

Smartwatch, 150 billion market: boom of those that report the heartbeat. The results of three field tests

by Rachel Kim – Technology Editor
written by Rachel Kim – Technology Editor

Smartwatch Market Surges past $150 Billion ​as Heart-Health Tracking Gains traction

Milan, Italy⁤ – ⁢August 31, 2025 ‍- The global smartwatch market has exploded, exceeding $150 billion ​in value,‌ fueled by a dramatic increase in consumer demand for devices capable of monitoring vital signs, particularly heart rate. Recent field tests demonstrate the growing⁢ accuracy and⁢ reliability of these⁣ features, positioning smartwatches not merely‌ as tech accessories but as increasingly valuable tools for preventative healthcare.

The rise of heart-health focused smartwatches represents a meaningful​ shift in the wearable technology​ landscape. ⁤What⁣ began as a​ trend for fitness enthusiasts is​ now attracting a broader demographic concerned⁣ with proactive health ⁢management.This‍ growth is projected to ​continue as technology improves and healthcare providers increasingly‌ integrate⁢ wearable data into‍ patient care. ‍The market’s expansion ⁢impacts consumers seeking‍ personalized health insights, manufacturers vying for market⁣ share, and the healthcare industry⁣ adapting to a​ new era of remote⁢ patient monitoring.Three independent field⁣ tests, conducted throughout 2025, assessed the accuracy of heart rate ​monitoring across leading smartwatch brands. Researchers at the university of Bologna found that the latest generation of smartwatches demonstrated a 95% correlation with ‌clinical-grade electrocardiogram (ECG) ⁤readings during moderate-intensity ‍exercise. A separate study by the Italian National Research Council, focusing on⁤ resting‌ heart rate variability, reported a 92% accuracy rate when compared to traditional chest-strap monitors. a consumer-focused trial involving 500 participants, organized‌ by the⁤ consumer advocacy group Altroconsumo, revealed that 88% of users found the heart rate data provided by their smartwatches to be reliable and useful ⁣for tracking ​their ‍fitness levels and identifying potential health anomalies.

These ‌findings come as the smartwatch market continues to evolve, with manufacturers​ incorporating increasingly sophisticated sensors and algorithms. the‌ initial copyright notice on⁢ related ⁤content, dated August 26, ‍2025, underscores the rapid ‌pace of development and the ongoing protection of intellectual property ‍in this dynamic sector.

0 comments
0 FacebookTwitterPinterestEmail
Health

Food Medicine: A Cardiologist’s Guide to Preventative Health

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Diet Key to Preventing Major Diseases, Cardiologist says

Bergamo, Italy – A cardiologist is ​emphasizing the critical role of diet in preventing ‌serious illnesses, stating that poor lifestyle choices contribute to an estimated‍ 80% of major disease⁤ cases. Speaking to‌ L’Eco di ⁤Bergamo, the physician highlighted‍ the ⁤protective benefits of​ a fiber-rich ⁤diet, linking it to reduced blood⁤ pressure, lower “bad” cholesterol (LDL), stabilized blood sugar, and a decreased ⁢risk of both cardiovascular disease​ and certain cancers.

The doctor stressed the⁤ importance‌ of understanding cholesterol levels, explaining that total cholesterol is a ⁣broad measure encompassing both positive and ‌negative​ elements.”The ⁣moast important aspect to monitor‍ is the LDL ⁢(Lipoproteine ​​with low density), ​the so-called ‘bad cholesterol’,” he said. He outlined⁢ several strategies for lowering ⁣LDL, including ​increased physical activity, a higher fiber ⁤intake, weight loss, consumption of extra virgin olive oil, ‌specific supplements,⁤ and, when necessary, medication.

The discussion also‌ covered⁤ recognizing‍ the symptoms of a heart attack, described ​as a ‌strong⁢ chest pain possibly radiating to the neck or arms – notably the left -‌ often accompanied by⁢ shortness of breath, nausea, cold​ sweats, fatigue, dizziness, or even fainting.​ The cardiologist drew a metaphorical connection between​ the heart’s contraction (systole) and relaxation (diastole) ⁢phases and the broader pursuit of life’s purpose,noting‌ that the ⁣heart’s contraction provides for the‌ needs of all organs.

0 comments
0 FacebookTwitterPinterestEmail
Health

Postpartum Bleeding & Heart Disease Risk: New Study Findings

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

postpartum Hemorrhage Increases Long-Term Heart Disease Risk, Study Finds

Table of Contents

A groundbreaking international study reveals that women who experience postpartum hemorrhage (PPH), a severe complication affecting approximately 14 million women annually, face a significantly elevated risk of cardiovascular diseases and thromboembolic events long after giving birth.

The Hidden cardiovascular Risks of Postpartum Hemorrhage

the research, published in *The Journal of Maternal-fetal & Neonatal Medicine*, highlights that PPH, which accounts for over 20% of maternal deaths worldwide, has long-term consequences beyond the immediate threat to a woman’s life. Emerging evidence indicates a strong link between PPH and increased risks of heart failure, stroke, ischemic heart disease, and blood clots.

According to Dr. manggala after Wardhana, from the Department of Obstetrics and Gynecology of the Faculty of medicine of the University of Airlangga in Indonesia, “For a long time, PPH has been considered an emergency that ends by stopping bleeding. Though, it can have durable effects on women’s heart health, even years after childbirth.”

Did You Know? The american Heart Association estimates that cardiovascular diseases cause approximately one in three deaths among women each year.

Quantifying the Risk: Cardiovascular and Thromboembolic Events

The systematic review and meta-analysis, encompassing ten studies conducted between 1986 and 2018 across various geographical locations, revealed that women with a history of PPH are 1.76 times more likely to develop cardiovascular conditions and 2.10 times more likely to experience thromboembolic incidents compared to those without such history.

Condition Risk Increase (PPH vs. No PPH)
Cardiovascular Diseases 1.76 times
Thromboembolic Events 2.10 times

The Critical window: up to 15 Years Postpartum

Researchers emphasize that while the elevated risk is most pronounced in the first year following childbirth, it can persist for up to 15 years, especially among women who experienced complications leading to high blood pressure during pregnancy, such as preeclampsia.

Pro Tip: Women with a history of PPH should discuss their cardiovascular risk with their healthcare provider and consider regular screenings.

Implications for Postpartum Care and public Health

The study authors advocate for a broader outlook on maternal care that extends beyond childbirth, including routine cardiovascular checks for women who experience severe bleeding.They believe that incorporating this knowledge into public health policy could lead to significant improvements in maternal health outcomes.

Until now, no systematic review or meta-analysis has thoroughly estimated the PPH association with the long-term risks of cardiovascular events and thromboembolia. Therefore, this study fills this deficiency and could help design postpartum care strategies to improve results in mothers at risk.

What steps should be taken to improve postpartum care for women who experience PPH? How can healthcare providers better communicate these long-term risks to patients?

Understanding Postpartum Hemorrhage: evergreen Insights

Postpartum hemorrhage remains a leading cause of maternal morbidity and mortality worldwide.While immediate interventions focus on stopping the bleeding, this research underscores the importance of recognizing and addressing the potential long-term cardiovascular consequences. Factors contributing to PPH include uterine atony, retained placental tissue, and trauma during delivery. Effective management requires prompt diagnosis, timely intervention, and comprehensive postpartum follow-up.

Frequently Asked Questions about Postpartum Hemorrhage and Cardiovascular Health

What is postpartum hemorrhage (PPH)?
Postpartum hemorrhage (PPH) is excessive bleeding after childbirth. It is a significant cause of maternal mortality worldwide.
How common is postpartum hemorrhage?
Approximately 14 million women globally experience postpartum hemorrhage annually.
What are the long-term health risks associated with postpartum hemorrhage?
Women who experience postpartum hemorrhage have a higher risk of developing cardiovascular diseases, such as heart failure and stroke, and thromboembolic events, like blood clots.
How much does postpartum hemorrhage increase the risk of cardiovascular issues?
The risk of cardiovascular conditions is approximately 1.76 times higher, and the risk of thromboembolic incidents is 2.10 times higher in women who have experienced postpartum hemorrhage.
For how long after childbirth does the increased risk from postpartum hemorrhage persist?
While the greatest risk is in the first year after childbirth, it can persist for up to 15 years, especially in women with pregnancy-related high blood pressure complications.
What can be done to mitigate the long-term risks of postpartum hemorrhage?
Routine cardiovascular check-ups could be offered to women who experience severe bleeding as part of their postpartum care.
Where was the research on postpartum hemorrhage and cardiovascular risks conducted?
The research included study populations from South Korea, the United Kingdom, Sweden, Canada, France, and the United States.

Disclaimer: This article provides general information and should not be considered medical advice. Consult with a healthcare professional for personalized guidance.

Share this important information with your friends and family! Leave a comment below to share your thoughts and experiences.

0 comments
0 FacebookTwitterPinterestEmail
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com